You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 May 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Wednesday that the US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act decision date for camizestrant to allow revie...
27 May 2026 - Biotechnology companies Circio Holding ASA (OSE:CRNA) and AaviGen GmbH on Wednesday announced a research collaboration to develop circVec-enhanced AAV vectors engineered for targeted, low-dose gene therapy for heart disease.This partner...
27 May 2026 - Rare disease pharmacy solutions provider Orsini announced on Tuesday that it is the contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod) 8.5 mg, a subcutaneous injection for the treatment of chronic hepatitis del...
27 May 2026 - ILC Dover, an Ingersoll Rand business involved in design and production for biopharmaceutical, pharmaceutical, and medical device markets, announced on Tuesday that it recently invested in two new core capabilities: Water for Injection ...
26 May 2026 - Neurology specialist Merz Therapeutics GmbH and its Chinese partner Jiangxi Kvvit Pharmaceutical Co Ltd on Tuesday announced an exclusive licence and collaboration agreement for INBRIJA (levodopa inhalation powder) and its proprietary i...
26 May 2026 - Swedish pharmaceutical company OncoZenge AB (Nasdaq First North Growth Market:ONCOZ) announced on Tuesday that it has received European regulatory approval to initiate its pivotal Phase III BEAM-Pain trial of BupiZenge (BZ003) for oral ...
26 May 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Tuesday that it will present new preclinical data on its TG-MVA prophylactic vaccine candidates against mpox at the World Congress on Infectious Diseases in Barcelona.Th...